Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Biology and Environment (3)
- Advanced Manufacturing (2)
- Clean Energy (18)
- Computer Science (1)
- Fusion and Fission (5)
- Fusion Energy (5)
- Isotopes (2)
- Materials (15)
- Materials for Computing (1)
- National Security (7)
- Neutron Science (25)
- Nuclear Science and Technology (20)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Supercomputing (17)
News Topics
- (-) Artificial Intelligence (2)
- (-) Machine Learning (2)
- (-) Neutron Science (2)
- 3-D Printing/Advanced Manufacturing (2)
- Big Data (2)
- Bioenergy (1)
- Biology (4)
- Biomedical (7)
- Biotechnology (1)
- Chemical Sciences (2)
- Clean Water (1)
- Climate Change (3)
- Computer Science (6)
- Coronavirus (7)
- Energy Storage (1)
- Environment (7)
- High-Performance Computing (1)
- Isotopes (1)
- Materials (2)
- Materials Science (1)
- Mathematics (1)
- Mercury (1)
- Molten Salt (1)
- Nanotechnology (3)
- Physics (1)
- Summit (4)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.